Wednesday, April 20th, 2016
|8:00 - 9:45 am||Novel approaches to enhance post-stroke functional outcome|
|8:00 - 8:15 am||Alia C. (Pisa, Italy)|
Reducing GABAergic inhibition improves forelimb motor function after focal cortical stroke in mice
|8:15 - 8:30 am||Abe K. (Okayama, Japan)|
Neuroprotective therapy both for acute ischemic stroke and ALS
|8:30 - 8:45 am||Lietzau G. (Stockholm, Sweden)|
Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the glucagon-like peptide-1 receptor agonist exendin-4
|8:45 - 9:00 am||Borlongan, Cesar (Florida, USA)|
Intravenously delivered IL2-targeted one marrow stem cell-derived exosomes, but not NCAM-Directed exosomes, hone to the spleen, dampen inflammation, and ameliorate stroke-induced functional deficits
|9:00 - 9:15 am||Blondeau N. (Paris, France)tba |
Alpha-Linolenic Acid nutritional intervention to support post-stroke functional recovery: the ultimate step preparing the ground of clinical trial?
|9:15 - 9:30 am||Sobey C. (Clayton, USA)|
Acute or delayed systemic administration of human amnion epithelial cells improves outcome after stroke
|9:30 - 9:45 am||Popa-Wagner A. (Rostock, Germany)|
Is the aged brain microenvironment refractory to cell therapy?